Proteolysis-targeting chimera (PROTAC) in cancer: design principles and applications on "undruggable" targets.

Lu X, Qin J, Dong S, Yuan Y, Zhang Z, Zhang B, Chen X, Gan X, Liang H, Liu F

DOI: 10.1186/s40364-026-00937-9
Published: 2026 May 21
Container: Biomarker research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40364-026-00937-9,
  title = {Proteolysis-targeting chimera (PROTAC) in cancer: design principles and applications on "undruggable" targets.},
  author = {Lu X and Qin J and Dong S and Yuan Y and Zhang Z and Zhang B and Chen X and Gan X and Liang H and Liu F},
  year = {2026},
  journal = {Biomarker research},
  doi = {10.1186/s40364-026-00937-9},
  url = {https://doi.org/10.1186/s40364-026-00937-9}
}

RIS

TY  - JOUR
TI  - Proteolysis-targeting chimera (PROTAC) in cancer: design principles and applications on "undruggable" targets.
AU  - Lu X
AU  - Qin J
AU  - Dong S
AU  - Yuan Y
AU  - Zhang Z
AU  - Zhang B
AU  - Chen X
AU  - Gan X
AU  - Liang H
AU  - Liu F
PY  - 2026
JO  - Biomarker research
DO  - 10.1186/s40364-026-00937-9
UR  - https://doi.org/10.1186/s40364-026-00937-9
ER  -

APA

X, L., J, Q., S, D., Y, Y., Z, Z., B, Z., X, C., X, G., H, L., & F, L. (2026). Proteolysis-targeting chimera (PROTAC) in cancer: design principles and applications on "undruggable" targets.. Biomarker research. https://doi.org/10.1186/s40364-026-00937-9

Source records

pubmed · retrieved 2026-09-26T05:47:22.040Z